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Abstract
Background: Previous study showed that extracts from Croton macrostachyus (Euphorbiaceae) exhibit analgesic effects
in acute pain models. The present study evaluates the antinociceptive properties of the methanol/methylene chloride
extract (MECM) of the stem bark of this plant using mice models of persistent inflammatory and neuropathic pain, and
assesses its mechanism of action.
Methods: MECM was tested on Complete Freund adjuvant (CFA)-induced persistent thermal and mechanical pain,
neuropathic pain induced by partial sciatic nerve ligation (PSNL), prostaglandin E2 (PGE2)-induced acute mechanical
hyperalgesia, as well as on nociception induced by capsaicin in mice. Mechanical hyperalgesia was assessed using von
Frey hair in awake mice. The mechanism of action of MECM was evaluated by using glibenclamide on PGE2-induced
hyperalgesia or rimonabant on capsaicin-induced pain.
Results: MECM administered orally at the doses of 250 and 500 mg/kg, induced long lasting and significant
antihyperalgesic effects on CFA-inflammatory and PSNL-induced neuropathic pain. MECM significantly reduced
the mechanical hyperalgesia induced by PGE2 either when administered preventively or therapeutically. MECM
also significantly and time dependently inhibited the capsaicin-induced nociception. These effects were not
affected by glibenclamide or by rimonabant.
Conclusions: The present results demonstrate that the oral administration of MECM to mice resulted in long
lasting antihyperalgesic activity in inflammatory and neuropathic pain as well as in acute and persistent pain.
The mechanism underlying the long lasting MECM antihyperalgesic effect is currently unknown, but might be
mediated, at least partially, through the modulation of TRPV1 receptors.
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Background
Pain is a subjective and unpleasant experience willing to
protect the organism against harmful stimuli. The un-
pleasant sensation in acute pain and the useless long-
term emotional experience of suffering in chronic pain
have turn pain to become an entire disease that needs
to be alleviated as early as possible. In addition, unre-
mitting pain is frequently associated with anxiety, de-
pression, loss of independence, and interference with
work and relationships. The anxiety and the emotion
resulting from pain, reciprocally strengthen the pain and
thereby, maintain a vicious circle that worse the patient
condition. Furthermore, chronic neuropathic pain can ac-
quire with time an important inflammatory component
[1, 2] which is thought to account for neuronal plasticity
associated to pain. Indeed, it has been shown that in both
neuropathic and inflammatory pain conditions various
neuronal cells proteins are up regulated, including TRPV1
receptors [3]. Apart from TRPV1 antagonists, the activity
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of TRPV1 channels can be modulated by cannabinoid re-
ceptors which are collocated in the same nerve endings or
by ATP sensitive potassium channels. These cell struc-
tures are potential targets for pain management.
For many years, research has been focused on seeking
medicine that can conveniently address chronic pain. But,
still more than 40 to 50 % of patients in routine practice
settings fail to achieve adequate relief especially those suf-
fering from neuropathic pain [4]. Thus, pain, especially
chronic pain, resulting from inflamed tissues or directly
from nerve injury are now considered to be a public
health problem of major proportions. Hence, there is a
great need for the development of new, safe and better an-
algesic drugs for the alleviation and control of acute and
chronic, inflammatory and neuropathic pain. Medicinal
plants are considered as an important source of active
molecules of pharmacological interest, given their effi-
ciency proved against many diseases and the fact that
more than 50 % of the actual manufactured drugs are
from plant or derivatives of plant compounds [5, 6].
Croton macrostachyus (Hochst) pipe cleaner ex and
Galinier, is a plant used in African folk medicine to treat
different ailments, including pain and inflammation [7, 8].
Indeed, previous studies have shown that aqueous and
organic extracts from the stem bark of C. macrostachyus
given orally, possess antinociceptive and anti-inflammatory
activities in distinct acute animal models [9]. The present
study aimed at providing additional insight about the anti-
nociceptive effects of the methanol/methylene chloride
extract of the stem bark of C. macrostachyus in different
models of chronic inflammatory and neuropathic pain and
to evaluate its preliminary mechanisms of action.
Methods
Plant collection and extraction
Plant material was harvested in Bagangté (West,
Cameroon) and identified at the Cameroon National
Herbarium in comparison to the existing Voucher spe-
cimen (5696/SRF/CAM). The stem bark was sun dried
and pulverized. Six kilograms of C. macrostachyus
powder were macerated in 10 L of a mixture of metha-
nol/methylene chloride (CH3OH/CH2Cl2, 1:1 v/v) for
2 days at room temperature, filtered and concentrated
at 45 and 65 °C successively, using a rotary evaporator.
This process yielded 160 g of CH3OH/CH2Cl2 extract,
which correspond to 2.67 % yield. This extract has been
shown to possess alkaloids, phenols, terpernoids and
flavonoids [9], including lupeol, betulin floridolide A,
hardwickic acid and 12-oxo-hardwickic acid [10].
Animals
Swiss mice (25–35 g) of both sexes, aged 6 to 8 weeks
were used in the present study. Animals were obtained
from the central animal house of the Department of
Pharmacology from Federal University of Santa Catarina,
Brazil. They were acclimatized for at least 1 week in the
laboratory at a controlled temperature (22 ± 1 °C), hu-
midity (50–80 %), under a 12-h light/dark cycle with free
access to standard commercialized rodent diet and
filtrated water. The number of mice used was the mini-
mum possible to determine consistent effects of the drug
treatments (See figures). All protocols were submitted
and approved by the Ethical Committee for use of Ani-
mals of the Federal University of Santa Catarina (proto-
col no. PP00496) and conformed to the guidelines for
the study of pain in awake animals established by the
International Association for the Study of Pain.
Experimentation
Mechanical hyperalgesia behaviour assessment
Mice were acclimatized for at least 1 hour in individual
transparent cages (9 × 7 × 11 cm) placed on an elevated
wire mesh platforms. They were evaluated for paw
withdrawal using 0.4 g von Frey hair (VFH, Stoelting,
Chicago, IL, USA). Each animal was essayed 10 times
and the result was expressed as percentage of response
(paw withdrawal) to the number of stimulations, as pre-
viously published [11].
Complete Freund Adjuvant (CFA) - induced mechanical
hyperalgesia
Before any treatment, the baseline percentage with-
drawal was measured. Then, animals were treated orally
with vehicle (10 ml/kg), MECM (250 or 500 mg/kg) or
gabapentin (used as positive control drug, 70 mg/kg).
One hour after treatment, they were slightly restrained
and received an intraplantar injection of 20 μl of CFA
(100 %) and returned in wire mesh plate form. The fre-
quency of response to von Frey hair was then evaluated
at 1, 2, 4, 6, 8 and 24 h time points after CFA injection.
After the 24 h hyperalgesia evaluation, animals received
another dose of treatment and were further kept un-
treated while evaluating pain behavior until the re-
sponse frequency was equal to that of control group
receiving vehicle [11]. Then they received once daily
treatment and were evaluated for pain sensation 24 h
after each administration until 14 days post CFA. The
aim of this protocol was to verify if repeated treatment
could result in a long lasting analgesic effect.
Neuropathic pain induced by sciatic nerve partial ligation
To evaluate neuropathic pain-like behavior, the procedure
was similar to that described previously [12]. Mice were
anaesthetized by intraperitoneal injection of chloral hy-
drate 7 % (0.8 ml/kg), after the measurement of the basal
response to mechanical stimulation with von Frey hair
0.4 g. The right common sciatic nerve was exposed at the
level of the mid-thigh, proximal to the nerve trifurcation.
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The exposed nerve was partially (1/3 to 1/2) ligatured
using 8.0 suture needles. Care was taken to preserve epi-
neural circulation. The tight was slowly stretched until the
ispilateral hind foot elicited a brief twitch. Then the inci-
sion was sutured and treated with iodine. Five days after
the surgical intervention, a second mechanical basal pain
behavior was assayed to assure the effectiveness of pain in-
stallation. Then, animals were treated orally either with ve-
hicle, MECM (500 mg/kg) or gabapentin (used as positive
control drug, 70 mg/kg) and hyperalgesia was tested 1, 2,
4, 6, 8 and 24 h time points post treatment on the right
hind paw. After the 24 h measurement, animals were
treated twice a day (10 a.m and 6 p.m) and neuropathic
pain-like behavior was evaluated the next day before and
2 h after the first administration of the day (10 a.m).
PGE2-induced mechanical hyperalgesia
After assessment of the basal reaction of male mice to
von Frey hair, animals were orally treated with vehicle
(DMSO/Tween), MECM (500 mg/kg) or dipyrone (used
as positive control drug, 120 mg/kg) and 1 hour later,
they received PGE2 (0.1 nmol/paw) under the subplantar
aponevreous. Frequency response to von Frey hair
stimulation was measured 1, 2, 4, 6 and 8 h time points
post PGE2 [13].
In another set of experiment, treatments were given
orally 1 hour after PGE2 (therapeutic) and pain was eval-
uated till 8 h post PGE2 injection. The post treatments
with MECM (500 mg/kg) or dipyrone 120 mg/kg, were
evaluated in absence and in presence of glibenclamide
(5 mg/kg, i.p), an inhibitor of ATP - sensitive potassium
channels. The inhibitor was used to evaluate the partici-
pation of ATP-dependant potassium channel in the anal-
gesic effects of MECM. Antagonist was administered
30 min before MECM or dipyrone.
CFA – induced thermal hyperalgesia
Male mice latency time of reaction against infrared radi-
ation (intensity 15 % in the paw), was measured and
animals were then treated orally with vehicle (10 mL/kg),
MECM (500 mg/kg p.o.) or dipyrone (120 mg/kg, p.o.).
One hour after the treatment, they were intraplantarly
injected with 20 μl of CFA and pain behavior was again
assessed 1, 2, 4, 6, 8 and 24 h time points after CFA injec-
tion, as previously described [14].
Capsaicin-induced spontaneous nociception
Male mice were treated with vehicle, MECM (500 mg/kg,
p.o) or with capsazepine (11.3 μg/paw) and acclimated in
glace funning for at least 20 min before challenged with
1.6 μg/paw of capsaicin. Pain behavior was evaluated at 1,
2, 4 or 6 h time points after MECM treatment. Different
groups of animals were used at each time point. After
capsaicin injection, animals were returned in individual
funning and observed for the consecutive 5 min. The time
the animal spent licking the injected paw was timed with
chronometer and consider as indicative of pain [15]. Cap-
sazepine used as positive control was injected in situ and
appropriate control was conducted.
To assess whether the effect of MECM was mediated
through cannabinoid CB1 receptors that are collocated in
the same neurons with TRPV1 capsaicin sensitive receptor
[16], the effect of the extract was assessed in animals previ-
ously treated with rimonabant (10 mg/kg, p.o), an inverse
agonist of CB1 receptor. WIN 55,212-2 ((R)-(+)-[2,3-Dihy-
dro-5-methyl-3[(4-morpholinyl)methyl] pyrrolo[1,2,3-de]-
1,4-benzoxazinyl]-(1-naphthalenyl) methanone, 3 mg/kg,
i.p) was used as positive control. Appropriate controls were
conducted both for rimonabant and WIN 55,212-2. In the
course of experiment, rimonabant was given 30 min before
WIN 55,212-2 and MECM and animals were challenged
with capsaicin 30 min after WIN 55,212-2 or 1 h after
MECM administrations. This time schedule was chosen
base on the time course effect of the extract in previous ex-
periments as well as that of the WIN 55,212-2 and rimona-
bant in the literature [17].
Drugs
Complete Freund Adjuvant (CFA), capsaicin, capsaze-
pine, Win 55,212-2, prostaglandine E2, dipyrone, gaba-
pentin and cremophore were purchased from Sigma
Chemical CO, (St. Louis, MO, USA). Glibenclamide was
obtained from RBI and rimonabant from Sanofi. Gabapen-
tin and dipyrone were prepared in saline. Plant extract
and Win 55,212-2 were prepared in saline containing 5 %
of DMSO and 5 % Tween 80 which was further used as
vehicle in control animals. Glibenclamide was prepared in
saline containing 2 % of DMSO and 2 % Tween 80. Capsa-
icin stock solution (10−2 M) was prepared by successively
dissolving capsaicin in 10 % ethanol, 10 % Tween 80 and
80 % NaCl 0.9 %. The stock solution was further diluted
in saline upon administration to 80 μg/ml. Stock solution
of capazepine (10−2 M) was prepared in 20 % ethanol and
further diluted upon administration to the concentration
of 565 μg/ml using saline. Prostaglandine E2 stock solu-
tion (10−3 M) was prepared in 10 % ethanol and further
diluted 200 folds to a final solution of 1.76 μg/ml using Sa-
line. Rimonabant was suspended in 5 % DMSO and 0.5 %
cremophore. In all cases, vehicle solutions were prepared
just before experiments and and used in control groups.
Statistical analysis
Data are expressed as mean ± standard error of the mean
of 5–7 individual animals. Data were analyzed by either
one way ANOVA followed by Tukey post hoc test or two
way ANOVA followed by Bonferonni as post hoc test
using the GraphPad Prism software (GraphPad Software
Inc., San Diego, CA). P < 0.05 was considered significant.
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Results
Effects of MECM on CFA – induced mechanical
hyperalgesia
CFA injection into the mice paw induced mechanical
hyperalgesia when assessed by von Frey stimulation as
evidenced by the significant (p < 0.001) increase in the
baseline frequency response. This hypersensitivity was
significantly reduced by previous treatment of animals
with gabapentin and also with MECM. It is worth noting
that following 2 day administration of MECM at the
dose of 500 mg/kg, the antihyperalgesic effect of MECM
was maintained for up to 5 days. The reinitiating of
treatment after the animals have recovered their hyper-
sensitivity induced a progressive and long lasting anal-
gesic effect, the higher dose being the most effective
(Fig. 1).
Effects of MECM on mechanical hyperalgesia in mice with
partial sciatic nerve ligation
Five days after surgery, a significant increase (p < 0.001)
on the baseline frequency response was observed in all
animals. In the acute treatment (Fig. 2a), oral adminis-
tration of MECM (500 mg/kg, p.o.) significantly reduced
the mechanical hyperalgesia caused by partial sciatic
nerve ligation. The effect of the extract as that of gaba-
pentin, started 1 h after administration. The antinocicep-
tive effects of the two substances were maintained for
up to 8 h; but 24 h after the administration, the sensitiv-
ity of treated animals was equal to that of control group.
When given twice a day and evaluated in the next days
(Fig. 2a), gabapentin did not show any long lasting effect
up to the end of the experiment while MECM progres-
sively and significantly inhibited the mechanical hyper-
algesia (Fig. 2a). In contrast, when the treatment was
given twice a day and pain behavior assessed 2 h after
the first treatment of the day, either extract or gaba-
pentin, almost completely inhibited the hyperalgesia
(Fig. 2b).
Effects of MECM on PGE2 – induced mechanical
hyperalgesia
Intraplantar injection of PGE2 resulted in a significant
(p < 0.01) hyperalgesia to mechanical stimulation when
assessed by von Frey hair. PGE2–induced hyperalgesia
was significantly reduced by dipyrone (120 mg/kg, p.o.)
and by MECM (500 mg/kg, p.o.) when both were given
as preventive treatment (Fig. 3a). As shown in Fig. 3b,
both substances significantly inhibited PGE2-induced
hyperalgesia when administered as a therapeutic scheme
of treatment. However, glibenclamide significantly re-
duced the antihyperalgesic effect of dipyrone but failed
to prevent that of MECM although an effect was ob-
served at the 4th hour (Fig. 3c).
Effects of MECM on CFA – induced thermal hyperalgesia
CFA injected in ventral aponevreous of mice’s paw induced
a significant (p < 0.01) thermal hyperalgesia. The reaction
latency time of animals was reduced by 60 % 1 hour after
CFA injection. Both dipyrone (120 mg/kg, p.o.) and MECM
(500 mg/kg, p.o.) given one hour before CFA, significantly
increased the latency time (Fig. 4a). The two drugs signifi-
cantly reduced the sensitivity to thermal stimulation by
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Fig. 1 Effects of oral administration of the methanol/methylene chloride extract of the stem bark of Croton macrostachyus (MECM) on the mechanical
hyperalgesia induced by von Frey hair (0.4 g) in CFA (20 μl/paw) inflamed mice paw. In persistent treatment, response to pain was evaluated before the
treatment of the day, when given. B = basal response to mechanical stimulation. N = 5; ap< 0.05; bp < 0.01; cp < 0.001 significantly different compared to
vehicle (ANOVA two way and Bonferoni as post hoc test)
Nguelefack et al. BMC Complementary and Alternative Medicine  (2015) 15:293 Page 4 of 9
24.5 and 37.3 %, respectively as calculated from area under
the curve (Fig. 4b).
Effects of MECM on capsaicin-induced pain
Oral administration of MECM induced a significant inhib-
ition of pain induced by intraplantar injection of capsaicin.
The extract was effective when dosed one hour after ad-
ministration and its effect lasted for up to 4 h (Fig. 5a).
It is well known that capsaicin activates TRPV1 cation
channels. These channels are found in the same C nerve
fibers with the cannabinoid CB1 receptors [16]. Thus, we
hypothesized that activation of these CB1 receptors could
inhibit the capsaicin induced pain. So, the effect of WIN
55,212-2 (a CB1 agonist) was tested and showed antinoci-
ceptive effect on this model. To evaluate whether the ef-
fect of MECM was mediated through CB1 receptors, its
activity as well as that of WIN 55,212-2 was evaluated in
animals pretreated with rimonabant (an antagonist of can-
nabinoid CB1 receptors). Rimonabant completely reversed
the antinociceptive effect of WIN 55,212-2 as expected,
but failed to inhibit the effect of MECM (Fig. 5b).
Discussion
The present study investigates the antinociceptive effects
of the methanol/methylene chloride extract of Croton
macrostachyus (MECM) in models of persistent inflam-
matory and neuropathic pain and explored its prelimin-
ary mechanism of action. Results demonstrated that
MECM possesses orally antinociceptive property when
assessed in both CFA and sciatic nerve partial ligation as
well as in prostaglandin E2 (PGE2)-induced acute pain.
MECM also showed significant inhibitory effect in cap-
saicin induced pain, an effect that was not prevented by
rimonabant, a CB1 receptor reverse agonist or by gliben-
clamide, a ATP- dependent potassium channel inhibitor.
It is important to mention, that the antinocicepetive
property of MECM as demonstrated in the present
paper corroborates many previous works carried out in
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Fig. 2 Effect of oral administration of the methanol/methylene chloride extract of the stem bark of Croton macrostachyus (MECM) on the
mechanical hyperalgesia assessed with von Frey hair (0.4 g) in mice paw after sciatic nerve partial ligation (PSNL). In panel (a), response to pain
was evaluated before the first administration of the day while in panel (b) it was evaluated 2 h after the first administration of the day. N = 5;
ap < 0.05; bp < 0.01; cp < 0.001 significantly different compared to vehicle at each time point. B1 = basal response to mechanical stimulation before
operation, B2 = basal response to mechanical stimulation 5 days after operation
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other plants belonging to the genus Croton [18–20].
However, new experiments should be conducted to iso-
late and chemically characterize the active compound(s)
present in the MECM.
Hyperalgesia resulting from CFA injection in animals’
paw is a well known and characterized model of pain in-
volving both the peripheral and the central nervous system.
Indeed, CFA injection induces the release of histamine
and serotonin from mast cells through the degranula-
tion process and activates inflammatory cells to release
cytokines (TNF-α, IL-1β, IL-6) and chemokines (MCP-
1, KC, IP-10) both at the periphery and at the central
nervous system [21, 22] Cytokines are responsible for
the hypersensitisation of peripheral and central neurons,
a phenomenon that includes the appearance of inducible
proteins, up-regulation and activation of various mem-
brane and intracellular pathways. It is now well recognized
that CFA up regulates and potentiates voltage-gated so-
dium channels, GluR1 and TRPV1 receptors [23–25]
which participate in the maintenance of persistent mech-
anical and thermal inflammatory pain. Herein, our data
demonstrated that MECM significantly reduced the mech-
anical hyperalgesia induced by intraplantar injection of
CFA. Moreover, the antinociceptive effect of MECM was
maintained for up to 5 days after two administrations in
the first 24 h. These results suggest that MECM might
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Fig. 3 Effect of oral administration of the methanol/methylene chloride extract of the stem bark of Croton macrostachyus (MECM) on the mechanical
hyperalgesia evaluated with von Frey hair (0.4 g) in PGE2 (0.1 nmol/paw) inflamed mice paw. In panel (a), animals were treated 1 hour before PGE2
injection and pain response was evaluated before treatment and after PGE2 injection. In panel (b) and (c), treatments were given orally 1 hour
after PGE2 and response to pain was evaluated before PGE2 injection and after treatment. N = 5;
ap < 0.05; bp < 0.01; cp < 0.001 significantly different
compared to vehicle. B = basal response to mechanical stimulation
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interfere with the acute pain sensitization as well as the
over expression of pain regulatory cytokines and proteins.
In other to verify this hypothesis, animal were left un-
treated until the sensitivity returns to the control point,
then the treatment was reinitiated. It was observed that
the MECM administered once a day, produced antihyper-
algesic effect that reappears after the third day, showing a
progressive effect. It can then be thought that MECM do
not inhibit the installation of pain but rather interact with
signaling pathways that induce mechanical pain in inflam-
matory conditions. Another possibility is that MECM may
be able to reduce the well-established chronic pain. This
hypothesis was evaluated by testing MECM on a well in-
stalled neuropathic pain induced by PSNL. MECM signifi-
cantly reduced the PSNL neuropathic pain. On this model
of pain generally known as resistant to treatment, MECM
almost completely inhibited the hyperalgesia 2 hours after
its oral administration. Relevantly, a long lasting effect of
MECM was observed in this model from the fourth day
after the initiation of the treatment. This effect was ob-
served during the 14 days of treatment. These results sug-
gest that MECM may have cumulative effects or may
interfere with slow regulatory processes such as proteins
and mediators expression. Further experiments are neces-
sary to prove this hypothesis.
Pro-inflammatory substances and proteins released or
up regulated by CFA and implicated in the mechanical
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Fig. 4 Effect of oral administration of the methanol/methylene
chloride extract of the stem bark of Croton macrostachyus (MECM)
on the thermal hyperalgesia in CFA inflamed mice paw. Treatments
were given 1 h before intraplantar injection of CFA (20 μl). N = 6
mice per group. B = basal response to thermal stimulation. *p< 0.05,
***p< 0.001compared to control (vehicle)































Capsaicin (1.6   g/paw)


















Fig. 5 Effect of oral administration of the methanol/methylene chloride
extract of the stem bark of Croton macrostachyus (MECM, 500 mg/kg, po)
on the spontaneous pain induced by capsaicin. Panel (a) shows the time
course effect of MECM in different groups of animals. Panel (b) presents
the effect of rimonabant (SR 141716, 10 mg/kg, po) on the analgesic
activity of MECM and WIN 55212–2 (Win, 3 mg/kg, ip) on nociception
induced by capsaicin. MECM was given 1 h before intraplantar injection
of capsaicin while rimonabant (10 mg/kg, p.o) was given per os 30 min
before Win and MECM. V = vehicle, cap = capsaicin, capz = capsazepine,
ext = extract. N = 4 (Vcap) to 7 mice per group. **p < 0.01, ***p < 0.001
significantly different compared to respective controls. # p < 0.01
significantly different compared to the same treatment
without rimonabant
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hyperalgesia including inducible nitric oxide synthase
and cyclooxygenase-2 [26]. Subsequent upregulation of
PGE2 production but also of PGE2 receptors have been
demonstrated both in inflammatory pain and in partial
sciatic nerve ligation [27]. In order to determine whether
MECM interferes with the PGE2 pathway, it was tested
as preventive and therapeutic scheme of treatment on
the mechanical hyperalgesia induced by this inflamma-
tory mediator. In both cases, MECM exhibited a signifi-
cant antihyperalgesic effect. As MECM was able to
reduce pain when given after PGE2 injection, it can be
conclude that this extract inhibits the downstream PGE2
pathway or interact with ion channels that are involve in
nerve action potential or nerve conductivity.
Opening of the ATP-sensitive potassium channels
(K-ATP) have been shown as the end mechanism of the
peripheral effect of many analgesics such as morphine
[28], dypirone [29], diclofenac [30], xylazine [31], sil-
denafil [32] and even plant derivatives [11]. In order to
determine whether or not this pathway is involved in
the activity of MECM, its antinociceptive effect was
evaluated in animals previously treated with glibencla-
mide, an inhibitor of K-ATP channels. Glibenclamide
failed to significantly antagonize the analgesic effect of
MECM, implying that its antinociceptive action is likely
unrelated with the activation of the K-ATP channels.
The linkage of PGE2 to its cellular receptors leads to
the activation of protein kinase C (PKC) and protein
kinase A (PKA) resulting in the release of sympathetic
amines and the sympathetic pain [33] or in the activa-
tion and phosphorylation of numbers of ion channels
[34], respectively. One of the channels target by PKA
and PKC activation is TRPV1 [35]. This channel is one
of the main receptors involve in the sensitization and
the maintenance of mechanical hyperalgesia in both in-
flammatory and neuropathic pain [36]. It can be acti-
vated by noxious heat, low pH or chemicals [37]. For
this reason, MECM was tested on thermal hyperalgesia
induced in CFA-inflamed mice, and relevantly, the ex-
tract significantly reduced the hyperalgesia, indicating a
possible inhibition of TRPV1 receptor.
To further ascertain the mechanism of action of
MECM, it was assesseed on pain induced by capsaicin, a
natural product that specifically and directly activates
TRPV1 receptor [38]. Here, MECM showed a significant
antinociception effect on capsaicin-induced pain that
was maintained for up to 4 h, strengthening the hypoth-
esis that the antihyperalgesic effect of this extract is at
least partially mediated by the inhibition of TRPV1
channel.
There is evidence that TRPV1 and CB1 receptors are
colocalized in the same neurons both at the periphery
and central nervous system and that the activation of
CB1 receptors may inhibit TRPV1 receptors [16, 38]. To
verify whether the inhibition of capsaicin-induced pain
observed with MECM is mediate by the activation of CB1
receptor, it was tested in animals that have been previously
treated with rimonabant, an antagonist of CB1 receptor.
Rimonabant completely reversed the antinociceptive effect
of WIN 55,212-2 (cannabinoid agonist), but failed to affect
that of MECM, suggesting that the effect of this extract is
not mediated through CB1 receptor.
Conclusions
Taking all together, the present study demonstrates that
methanol/methylene chloride extract of the stem bark of
Croton macrostachyus possesses relevant oral antinocicep-
tive effects both when assessed in acute, chronic, inflam-
matory and neuropathic pain. The long lasting MECM
antinociceptive effect seems to be mediated, at least
partially, through the modulation of TRPV1 receptors.
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